DE69834194T2 - Oberfläche-exponierte proteine von chlamydia pneumoniae - Google Patents

Oberfläche-exponierte proteine von chlamydia pneumoniae Download PDF

Info

Publication number
DE69834194T2
DE69834194T2 DE69834194T DE69834194T DE69834194T2 DE 69834194 T2 DE69834194 T2 DE 69834194T2 DE 69834194 T DE69834194 T DE 69834194T DE 69834194 T DE69834194 T DE 69834194T DE 69834194 T2 DE69834194 T2 DE 69834194T2
Authority
DE
Germany
Prior art keywords
seq
proteins
pneumoniae
protein
kda
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69834194T
Other languages
German (de)
English (en)
Other versions
DE69834194D1 (de
Inventor
Svend Birkelund
Gunna Christiansen
Katrine Knudsen
Anna-Sofie Hebsgaard Pedersen
Per Mygind
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOKE DIAGNOSTICS APS
Original Assignee
LOKE DIAGNOSTICS APS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOKE DIAGNOSTICS APS filed Critical LOKE DIAGNOSTICS APS
Publication of DE69834194D1 publication Critical patent/DE69834194D1/de
Application granted granted Critical
Publication of DE69834194T2 publication Critical patent/DE69834194T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/125—Gram-negative bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE69834194T 1997-06-23 1998-06-19 Oberfläche-exponierte proteine von chlamydia pneumoniae Expired - Lifetime DE69834194T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK74497 1997-06-23
DK74497 1997-06-23
PCT/DK1998/000266 WO1998058953A2 (en) 1997-06-23 1998-06-19 Surface exposed proteins from chlamydia pneumoniae

Publications (2)

Publication Number Publication Date
DE69834194D1 DE69834194D1 (de) 2006-05-24
DE69834194T2 true DE69834194T2 (de) 2007-03-29

Family

ID=8097044

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69834194T Expired - Lifetime DE69834194T2 (de) 1997-06-23 1998-06-19 Oberfläche-exponierte proteine von chlamydia pneumoniae

Country Status (13)

Country Link
US (2) US7264941B1 (cg-RX-API-DMAC10.html)
EP (1) EP1007685B1 (cg-RX-API-DMAC10.html)
JP (1) JP4160640B2 (cg-RX-API-DMAC10.html)
CN (1) CN1249233C (cg-RX-API-DMAC10.html)
AT (1) ATE323164T1 (cg-RX-API-DMAC10.html)
AU (1) AU749382B2 (cg-RX-API-DMAC10.html)
BR (1) BR9810288A (cg-RX-API-DMAC10.html)
CA (1) CA2294651A1 (cg-RX-API-DMAC10.html)
DE (1) DE69834194T2 (cg-RX-API-DMAC10.html)
DK (1) DK1007685T3 (cg-RX-API-DMAC10.html)
ES (1) ES2264810T3 (cg-RX-API-DMAC10.html)
PT (1) PT1007685E (cg-RX-API-DMAC10.html)
WO (1) WO1998058953A2 (cg-RX-API-DMAC10.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6710033B1 (en) 1996-08-14 2004-03-23 Vanderbilt University Methods and treatment of multiple sclerosis
US6890526B2 (en) 1997-05-06 2005-05-10 Vanderbilt University Methods and reagents for the treatment of multiple sclerosis
US6649370B1 (en) * 1998-10-28 2003-11-18 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
EP1129202A2 (en) * 1998-10-28 2001-09-05 Aventis Pasteur Limited Chlamydia antigenes and corresponding dna fragments and uses thereof
US6872814B2 (en) * 1998-10-29 2005-03-29 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
NZ512308A (en) * 1998-12-01 2004-01-30 Aventis Pasteur Chlamydia antigens and corresponding DNA fragments and uses thereof
AU3790900A (en) 1998-12-01 2000-06-19 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
EP2172214A3 (en) 1999-03-12 2011-03-16 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
WO2000066739A2 (en) * 1999-05-03 2000-11-09 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
CA2385325C (en) * 1999-09-20 2012-04-10 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
US20010048927A1 (en) 2000-02-01 2001-12-06 Richard Stephens Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia
ATE440861T1 (de) * 2000-07-03 2009-09-15 Novartis Vaccines & Diagnostic Immunisierung gegen chlamydia pneumoniae
US7105171B2 (en) 2002-03-07 2006-09-12 The Regents Of The University Of California Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
EP3452197A4 (en) 2016-05-04 2020-01-22 Children's Hospital & Research Center at Oakland FAST EXTRACTION OF NUCLEIC ACIDS FROM CLINICAL SAMPLES FOR DOWNSTREAM APPLICATIONS
US20220221456A1 (en) * 2019-05-06 2022-07-14 Arocell Ab Respiratory infection detection and classification

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU692889B2 (en) * 1994-08-03 1998-06-18 Hitachi Chemical Company, Ltd. Monoclonal antibodies having a reactivity specific to Chlamydia pneumoniae, method for production of the monoclonal antibodies, such antibody producing cells, method for production of the cells, method for detection and/or measurement of Chlamydia pneumoniae, reagents for the method, method and agents for diagnosis of chlamydia pneumoniae infection
CN100365017C (zh) 1994-09-20 2008-01-30 日立化成工业株式会社 肺炎衣原体抗原多肽
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof

Also Published As

Publication number Publication date
ATE323164T1 (de) 2006-04-15
US20080226679A1 (en) 2008-09-18
JP2002510970A (ja) 2002-04-09
EP1007685A2 (en) 2000-06-14
ES2264810T3 (es) 2007-01-16
WO1998058953A2 (en) 1998-12-30
AU749382B2 (en) 2002-06-27
PT1007685E (pt) 2006-08-31
AU8011998A (en) 1999-01-04
DK1007685T3 (da) 2006-08-14
WO1998058953A3 (en) 1999-03-18
US7264941B1 (en) 2007-09-04
DE69834194D1 (de) 2006-05-24
CN1249233C (zh) 2006-04-05
BR9810288A (pt) 2000-09-19
CN1261403A (zh) 2000-07-26
EP1007685B1 (en) 2006-04-12
JP4160640B2 (ja) 2008-10-01
CA2294651A1 (en) 1998-12-30

Similar Documents

Publication Publication Date Title
DE69232956T2 (de) Verbesserungen der diagnose und der prophylaxe von borrelia burgdorferi
EP0643974B1 (de) Impfstoff gegen die Lyme-Krankheit
EP0506868B2 (de) Immunologisch aktive proteine von borrelia burgdorferi, zusammenhängende testkits und impfstoff
DE69632625T2 (de) Mykrobakterielle proteine, mikroorganismen welche diese produzieren und ihre verwendung als impfstoff und zum nachweis von zuberkulose
DE69333802T2 (de) Äusseres membranprotein von haemophilus
DE69630457T2 (de) Verbindungen zur immunotherapie und diagnose von tuberkulose
DE69434681T2 (de) VAKZINE FÜR -i(BRANHAMELLA CATARRHALIS)
DE69333585T2 (de) Gereinigtes vakuolisierendes toxin aus helicobacter pylori und methoden zu dessen verwendung
DE69735715T2 (de) Cholin-bindendes Protein, welches als gegen Pneumokokken gerichtetes Vakzin verwendet wird
DE60036698T2 (de) Chlamydia-antigene und entsprechende dna-fragmente und deren verwendungen
DE60037900T2 (de) Chlamydia antigene und entsprechende dna-fragmente und ihre verwendungen
US20080226679A1 (en) Novel surface exposed proteins from chlamydia pneumoniae
DE60120621T2 (de) Lawsonia intracellularis Impfstoff
DE69016129T2 (de) Vakzin gegen Escherichia coli.
DE69930166T2 (de) Verfahren und zusammensetzungen für impfung mit dem pseudomonas aeruginosa v-antigen
DE69835682T2 (de) Oberflächenantigene und proteine für zusammensetzungen zu diagnose und vorbeugung der lyme-kkrankheit
DE3650571T2 (de) Hauptprotein der Aussenmembran von Chlamydia
DE69419966T2 (de) Impstoff gegen Streptococcus suis-Infektion
DE69214277T2 (de) Dna-sequenzen, die für die virulente eigenschaft von -i(streptococcus suis) kodieren, und teile davon, polypeptide und antikörper die sich davon ableiten und deren verwendung für diagnose und prophylaxe der infektion mit streptococcus suis in säugetieren, insbesondere in menschen
DE3856240T2 (de) Herstellung der p1 proteine und impfstoffe gegen gonorrhöe
DE69232483T2 (de) Mycobacteriumprotein und dessen verwendung
DE69333560T2 (de) Transport und expression eines hybriden oberflächenproteins an der oberfläche von grampositiven bakterien
DE69133276T2 (de) Mit der familie der hämolysin-toxine verwandte antigene eisen-ubnterdrückende proteine des n. meningitis
DE68916424T2 (de) Pasteurella-impfstoff.
DE69331377T2 (de) Verfahren und zusammensetzungen zur diagnose der katzenkratzkrankheit und der bakteriellen angiomatose

Legal Events

Date Code Title Description
8364 No opposition during term of opposition